Civentichem, LLC
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Civentichem, LLC - overview
Established
1994
Location
Cary, NC, US
Primary Industry
Pharmaceuticals
About
Civentichem, LLC is a chemistry-focused firm specializing in custom research and manufacturing services for diverse industries, including pharmaceuticals and biotechnology, ensuring innovative solutions are tailored to client needs. Founded in 1994 and headquartered in Cary, US, Civentichem, LLC provides custom research and manufacturing services in chemistry. The company operates under the leadership of CEO Bhaskar Venepalli, who has a background in establishing successful ventures. Civentichem was acquired by Sterling Pharma Solutions Ltd.
, a portfolio company of GHO Capital, in April 2019. The firm has completed a total of 1 deal as of the latest information available. Civentichem specializes in delivering comprehensive custom research and manufacturing services in chemistry, operating as an ISO9001 certified organization. Their offerings include the development of building blocks, intermediates, and compounds tailored to meet the specific needs of clients in pharmaceuticals, biotechnology, and agrochemicals.
By addressing complex chemical challenges, Civentichem supports advancements in drug discovery and development, serving a diverse clientele that includes research institutions and multinational corporations primarily across North America, Europe, and Asia. Civentichem generates revenue through a structured model focused on B2B partnerships. The company works directly with clients to create contracts for custom synthesis of chemical compounds, which often include specific project scopes and pricing that reflect the complexity and quantity of services provided. This approach fosters long-term relationships and repeat business, emphasizing the company's commitment to customized chemical solutions.
Following its acquisition in April 2019, Civentichem plans to strengthen its foothold in the market through enhanced product offerings and expansion into new geographic regions. Upcoming developments are focused on new custom synthesis solutions to be launched by the end of 2023. The firm aims to penetrate additional markets in Europe and Asia by 2025, leveraging the resources and support from Sterling Pharma Solutions to facilitate this expansion.
Current Investors
Sterling Pharma Solutions Limited
Primary Industry
Pharmaceuticals
Sub Industries
Pharmaceutical Research & Development
Website
www.civentichem.com
Verticals
Manufacturing
Company Stage
Add-on
Total Amount Raised
Subscriber access only
Civentichem, LLC - deals
| Deals Type | Deal Status | Target (s) | Deal Date | Investor(s) | Seller(s) | Deal size (Mn) | Enterprise value (Mn) | Post-money valuation (Mn) | EBITDA multiple (x) | Revenue multiple (x) | Lead partner (s) |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Add-on | Completed | Civentichem, LLC | - |
Displaying 1 - 1 of 1
Civentichem, LLC - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.